Skip to content
StockMarketAgent
Direct answer
XOM trades against a final fair-value range of $113.02-$174.69, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $113, high $175, with mid-point at $139.
Stock analysis

XOM Exxon Mobil Corporation fair value $139–$175

XOM
By StockMarketAgent.AI team· supervised by
Analizado: 2026-05-08Próxima actualización: 2026-08-08Methodology v2.4Archetype: CyclicalNYSE · Energy
View archive
Precio
$144.64
▼ -5.19 (-3.59%)
Valor razonable
$139
$139–$175
Calificación
Mantener
confidence 81/100
Potencial alcista
-3.6%
upside to fair value
Margen de seguridad
$118.53
buy below · 15%
Capitalización bursátil
$599.5B
P/E fwd 14.2
Respaldo en inglésES
Mostrando la fuente en inglés mientras traducimos
Este informe aún no se ha traducido. Actualice en unos minutos una vez que la cola de traducción se ponga al día.

§1 Resumen ejecutivo

  • Composite fair value $139 with high case $175.
  • Implied downside of 3.6% to fair value.
  • Moat 6.5/10 · confidence 81/100 · Cyclical.
  • Trades close to fair value, so the margin of safety is limited either way.
Fair value
$139
Margin of safety
-3.7%
Confidence
81/100
Moat
6.5/10

Educational analysis only — not financial advice. Always do your own due diligence.

$144.64Price
FV $139.45
High $174.69

XOM trades against a final fair-value range of $113.02-$174.69, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.

  • Scale and Cost Advantage
    Premier integrated upstream and downstream operations provide structural cost advantages and margin capture across the entire value chain.
  • Asset Quality
    Highly advantaged upstream positioning, particularly in the Permian Basin and Guyana, secures long-duration, low-breakeven production.
  • Bull thesis
    Hold rating driven by limited upside to our $139.45 fair value estimate and high cycle timing uncertainty.

§2 Caso bajista

A rapid acceleration of global energy transition policies combined with a synchronized global recession would severely compress both volumes and realized margins. In this scenario, Exxon's heavy upstream capital commitments become stranded or yield sub-cost-of-capital returns, forcing a structural downward re-rating of the terminal multipleTerminal multipleThe exit P/E or EV/EBITDA we apply to the final year of an explicit forecast. Anchored to the business's long-run quality and the prevailing risk-free rate. well below the 12x cyclical floor.

Cómo puede fallar esta tesis

Commodity Price Collapse

· Low

A sustained structural decline in crude oil prices below $50/bbl due to chronic oversupply and weakening demand, rendering marginal upstream assets economically unviable.

FV impact
Downside to $81.71 (5.8% discount rate, 1.0% terminal growth)
Trigger
2-3 Years

Stranded Asset Realization

· Medium

Aggressive global environmental regulations and carbon pricing mechanisms force the premature write-down of significant long-duration upstream and downstream reserves.

FV impact
Downside below $113.02 floor
Trigger
5-7 Years

Capital Misallocation Deflation

· Medium

The current $25.9B peak capital expenditure cycle fails to generate requisite returns, structurally depressing ROIC and forcing a persistent discount to net asset value.

FV impact
Downside to $103.04
Trigger
3-5 Years
Señales de alerta temprana a vigilar
MétricaActualUmbral de activación
Operating margins compress below the 11.57% historical mid-cycle median.MonitorDeterioration versus the report thesis
Capital expenditures systematically exceed targeted peak levels without revenue proportionality.MonitorDeterioration versus the report thesis
Operating cash flow to net income ratio falls below 1.2x, signaling earnings quality degradation.MonitorDeterioration versus the report thesis
Significant downward revisions in upstream reserve life or realization estimates.MonitorDeterioration versus the report thesis
Failure to maintain a 14x terminal multiple due to shifting institutional ESG mandates.MonitorDeterioration versus the report thesis

§3 Historial financiero

Cuenta de resultados — últimos seis períodos
ConceptoT−0T−1T−2T−3T−4CAGR
Período2021-12-312022-12-312023-12-312024-12-312025-12-31Trend
Ingresos$398.68B$334.70B$339.25B$323.91B-5.1%
Beneficio bruto$103.07B$84.14B$76.74B$71.24B-8.8%
Beneficio operativo$64.03B$44.46B$39.65B$33.94B-14.7%
Beneficio neto$55.74B$36.01B$33.68B$28.84B-15.2%
BPA (diluido)$5.39$13.26$8.89$7.84$6.70+5.6%
EBITDA$102.59B$74.27B$73.31B$67.86B-9.8%
I+D
SG&A$10.10B$9.92B$9.98B$11.13B+2.5%

Puntuaciones de calidad

Piotroski F-score
5 / 9
Compuesto de calidad 0–9
Altman Z-score
4.54
Riesgo de quiebra (>3 seguro)
OCF / Beneficio neto
1.8×
>1 indica alta calidad de los beneficios
Umbral de calidad contable
Pass
Umbral ajustado por sector
ROIC
10.9%
Rentabilidad del capital invertido
Sección 3

Numbers analysis

Asignación de capital

Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.

Suscriptores individuales — desde §411 secciones más

Leer el análisis completo — 11 secciones más.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

Informe completo para cada ticker cubierto
24 meses de archivo de calificaciones
Briefings de lista de seguimiento + alertas de cambio de calificación
Exportación PDF + DOCX en cualquier idioma
Comenzar prueba gratuita
Cancela cuando quieras.
FAQ

XOM — frequently asked questions

  1. Based on our latest independent analysis, XOM trades close to fair value. The current price is $145 versus a composite fair-value midpoint of $139 (range $113–$175), which implies roughly 3.6% downside to the midpoint.
Related coverage

Names readers of XOM also follow

Same archetype: cyclical